RAPT Therapeutics, Inc. ( RAPT )

Other

Common Stock

4,956

-^{footnote F3}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

2,813

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,063

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,618

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

4,561

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

32,229

-^{footnote F6}

Footnote F3 (price): Pursuant to the Merger Agreement, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the total number of Shares issuable in settlement… Full note on SEC EDGAR
Footnote F6 (price): Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and exercisable as of immediately prior to the Effective Time. At the… Full note on SEC EDGAR

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

478

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

484

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,063

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

560

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,618

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,072

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

4,561

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

7,650

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

32,229

-^{footnote F6}

Mar 3, 2026

Other

Common Stock

4,956

-^{footnote F3}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

2,813

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

498

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

938

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

938

-^{footnote F6}

Footnote F3 (price): Pursuant to the Merger Agreement, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the total number of Shares issuable in settlement… Full note on SEC EDGAR
Footnote F6 (price): Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and exercisable as of immediately prior to the Effective Time. At the… Full note on SEC EDGAR

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

799

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

938

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

938

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

402

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,063

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,618

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

4,561

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

32,229

-^{footnote F6}

Mar 3, 2026

Other

Common Stock

4,956

-^{footnote F3}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

824

-^{footnote F6}

Footnote F3 (price): Pursuant to the Merger Agreement, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the total number of Shares issuable in settlement… Full note on SEC EDGAR
Footnote F6 (price): Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and exercisable as of immediately prior to the Effective Time. At the… Full note on SEC EDGAR

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

25,000

-^{footnote F5}

Mar 3, 2026

Other

Common Stock

4,956

-^{footnote F3}

Footnote F3 (price): Pursuant to the Merger Agreement, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the total number of Shares issuable in settlement… Full note on SEC EDGAR
Footnote F5 (price): Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and exercisable as of immediately prior to the Effective Time. At the… Full note on SEC EDGAR

Mar 3, 2026

Rodney Kb Young - Officer

Other

Common Stock

3,304^{footnote F3}

-^{footnote F4}

Mar 3, 2026

Rodney Kb Young - Officer

Derivative

Employee Stock Option (right to buy)

17,501

-^{footnote F6}

Mar 3, 2026

Rodney Kb Young - Officer

Derivative

Employee Stock Option (right to buy)

69,271

-^{footnote F7,F8}

Mar 3, 2026

Rodney Kb Young - Officer

Derivative

Employee Stock Option (right to buy)

7,500

-^{footnote F6}

Mar 3, 2026

Rodney Kb Young - Officer

Derivative

Employee Stock Option (right to buy)

8,125

-^{footnote F6}

Mar 3, 2026

Rodney Kb Young - Officer

Derivative

Employee Stock Option (right to buy)

8,501

-^{footnote F6}

Mar 3, 2026

Rodney Kb Young - Officer

Derivative

Employee Stock Option (right to buy)

11,251

-^{footnote F6}

Mar 3, 2026

Rodney Kb Young - Officer

Derivative

Employee Stock Option (right to buy)

80,250

-^{footnote F6}

Footnote F3 (shares): The number of shares was adjusted to reflect the 1-for-8 reverse stock split effected by the Issuer on June 16, 2025.
Footnote F4 (price): Pursuant to the terms of the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Offer Price.
Footnote F6 (price): Pursuant to the terms of the Merger Agreement, each stock option Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and… Full note on SEC EDGAR
Footnote F7 (price): Pursuant to the terms of the Merger Agreement, each stock option that is unvested as of immediately prior to the Effective Time and was granted after March 1, 2025 (a "2025 Option") was cancelled and converted into a cash-based award of Parent (a "Converted Option"), which shall… Full note on SEC EDGAR
Footnote F8 (price): Each Converted Option (and the right to receive the Converted Option Consideration) shall be subject to the same terms and conditions (including vesting, forfeiture and acceleration provisions) that were applicable to the corresponding 2025 Option immediately prior to the… Full note on SEC EDGAR

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

6,876

-^{footnote F6}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

7,000

-^{footnote F6}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

9,375

-^{footnote F6}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

64,375

-^{footnote F6}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

58,333

-^{footnote F7,F8}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Other

Common Stock

4,648^{footnote F3}

-^{footnote F4}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

1,225

-^{footnote F6}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

1,035

-^{footnote F6}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

3,125

-^{footnote F6}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

2,500

-^{footnote F6}

Mar 3, 2026

Dirk G. Brockstedt - Officer

Derivative

Employee Stock Option (right to buy)

6,250

-^{footnote F6}

Footnote F3 (shares): The number of shares was adjusted to reflect the 1-for-8 reverse stock split effected by the Issuer on June 16, 2025.
Footnote F4 (price): Pursuant to the terms of the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Offer Price.
Footnote F6 (price): Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and exercisable as of immediately prior to the Effective Time. At the… Full note on SEC EDGAR
Footnote F7 (price): Pursuant to the terms of the Merger Agreement, each stock option that is unvested as of immediately prior to the Effective Time and was granted after March 1, 2025 (a "2025 Option") was cancelled and converted into a cash-based award of Parent (a "Converted Option"), which shall… Full note on SEC EDGAR
Footnote F8 (price): Each Converted Option (and the right to receive the Converted Option Consideration) shall be subject to the same terms and conditions (including vesting, forfeiture and acceleration provisions) that were applicable to the corresponding 2025 Option immediately prior to the… Full note on SEC EDGAR

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

31,250

-^{footnote F6}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

34,375

-^{footnote F6}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

218,250

-^{footnote F6}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

371,875

-^{footnote F7,F8}

Mar 3, 2026

Brian Russell Wong - Officer

Other

Common Stock

64,102^{footnote F3}

-^{footnote F4}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

25,000

-^{footnote F6}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

8,334

-^{footnote F6}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

10,417

-^{footnote F6}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

7,500

-^{footnote F6}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

18,750

-^{footnote F6}

Mar 3, 2026

Brian Russell Wong - Officer

Derivative

Employee Stock Option (right to buy)

37,500

-^{footnote F6}

Footnote F3 (shares): The number of shares was adjusted to reflect the 1-for-8 reverse stock split effected by the Issuer on June 16, 2025.
Footnote F4 (price): Pursuant to the terms of the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Offer Price.
Footnote F6 (price): Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and exercisable as of immediately prior to the Effective Time. At the… Full note on SEC EDGAR
Footnote F7 (price): Pursuant to the terms of the Merger Agreement, each stock option that is unvested as of immediately prior to the Effective Time and was granted after March 1, 2025 (a "2025 Option") was cancelled and converted into a cash-based award of Parent (a "Converted Option"), which shall… Full note on SEC EDGAR
Footnote F8 (price): Each Converted Option (and the right to receive the Converted Option Consideration) shall be subject to the same terms and conditions (including vesting, forfeiture and acceleration provisions) that were applicable to the corresponding 2025 Option immediately prior to the… Full note on SEC EDGAR

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

2,083

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

521

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

521

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,917

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

417

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

938

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

938

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,063

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

1,618

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

4,561

-^{footnote F6}

Mar 3, 2026

Derivative

Director Stock Option (right to buy)

32,229

-^{footnote F6}

Mar 3, 2026

Other

Common Stock

4,956

-^{footnote F3}

Footnote F3 (price): Pursuant to the Merger Agreement, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the total number of Shares issuable in settlement… Full note on SEC EDGAR
Footnote F6 (price): Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and exercisable as of immediately prior to the Effective Time. At the… Full note on SEC EDGAR

Mar 3, 2026

Scott Braunstein

Other

Common Stock

4,956

-^{footnote F3}

Mar 3, 2026

Scott Braunstein

Derivative

Director Stock Option (right to buy)

25,000

-^{footnote F5}

Footnote F3 (price): Pursuant to the Merger Agreement, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the total number of Shares issuable in settlement… Full note on SEC EDGAR
Footnote F5 (price): Pursuant to the terms of the Merger Agreement, each stock option that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was accelerated and became fully vested and exercisable as of immediately prior to the Effective Time. At the… Full note on SEC EDGAR

Jan 30, 2026

Scott Braunstein

Grant or award

Common Stock

4,956

$0.00

Jan 30, 2026

Grant or award

Common Stock

4,956

$0.00

Jan 30, 2026

Grant or award

Common Stock

4,956

$0.00

Jan 30, 2026

Grant or award

Common Stock

4,956

$0.00

Jan 30, 2026

Grant or award

Common Stock

4,956

$0.00

Jan 30, 2026

Grant or award

Common Stock

4,956

$0.00

Jun 21, 2025

Grant or award

Director Stock Option (right to buy)

25,000

$0.00

May 29, 2025

Grant or award

Director Stock Option (right to buy)

257,832

$0.00

Mar 31, 2025

Grant or award

Director Stock Option (right to buy)

61,202

$1.06

$65K

Dec 23, 2024

Other

Common Stock

1,352,008

Dec 23, 2024

Other

Common Stock

1,599,417

Dec 23, 2024

Other

Warrant (right to purchase)

1,352,008

Dec 23, 2024